Home » Topics » BioWorld Science

BioWorld Science
RSS

Yamanouchi claims PCP antagonist for dementia

March 15, 1996

BB-3644 in development for multiple sclerosis

March 15, 1996

Lexipafant evaluated for MS treatment

March 15, 1996

Sparta acquires Lexin

March 15, 1996

Yissum claims novel anticonvulsants

March 15, 1996

Elan, Athena to merge

March 15, 1996

BASF to acquire majority stake in Hokuriku

March 15, 1996

Bayer acquires rights to CryoLife technology

March 15, 1996

CIMA signs agreements for OraSolv drug delivery technology

March 15, 1996

Arris, P&U collaborate on combinatorial chemistry

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...